Become a Customer
Open a purchasing account and submit the required facility, licensing, and payment information for onboarding review.
Start Account SetupSearch by NDC, request a custom quote for hard-to-find products, or open a purchasing account with a distributor serving licensed healthcare buyers in 43 states.
Open a purchasing account and submit the required facility, licensing, and payment information for onboarding review.
Start Account SetupBest for buyers who already know the NDC, brand name, or generic name and want to move quickly to product review or RFQ.
Search Drug CatalogBest for unlisted products, alternate presentations, shortage sourcing, or items you cannot find in current catalog results.
Submit a Custom QuoteBest for buyers looking for information specific to their facility or industry and learning how Premium Rx National can help.
Explore Facility SupportAlready a current customer? Go straight to Drug Search for product lookup and quote requests.
Use Drug Search to locate products by NDC, brand, generic, strength, or dosage form.
Not a customer yet? You can still submit a quote request. If you can't find an item online, that doesn't mean we can't source it. Please request a custom quote.
Valid state and federal licensure is required for regulated pharmaceutical purchasing. Pharmaceutical sales are restricted to licensed healthcare facilities only, and we do not service end-users.
Built for pharmacies, hospitals, clinics, and healthcare teams that need dependable availability and responsive communication.
We've been a leading provider for over 17 years, delivering dependable service with a practical, customer-first approach.
We service 3,100 facilities and are operationally ready to handle the needs - from small to large.
With access to thousands of drugs and medical supplies, we provide exceptional availability when facilities need products quickly.
We proudly serve agencies including the DoD, VA, IHS, and DHHS with trusted pharmaceutical and medical supply solutions.
View agency capability detailsAdd one or multiple drugs to your RFQ cart and submit all requirements in a single request.
Consistent support for long-term buyers with transparent responses and follow-through.

Premium Rx National, LLC is fully compliant with FDA DSCSA serialization requirements and can establish an interoperable EPCIS connection with your facility. We have proudly partnered with TrackTraceRX, a premier DSCSA solution provider since 2015.
We pride ourselves on helping customers navigate drug shortages and supply issues for their facilities. Our knowledgeable team is available Monday-Friday, 8:00 AM - 5:00 PM ET to help in times of need.
We are an authorized distributor for Hikma, Nephron Pharmaceuticals, and X-Gen Pharmaceuticals DJB.
We supply brand-name and generic pharmaceuticals including injectables, tablets, biologics, vaccines, and OTC products.
Search catalog pages, add products to RFQ cart, and send one request with your required quantities.
Our licensing footprint supports healthcare procurement teams across most mainland states and the District of Columbia.
PRN stands out in the pharmaceutical distribution industry. Their proactive approach, especially during drug shortages, ensures we never feel overwhelmed or unsupported.
You're not only helping me; you're also assisting our Veterans in getting what they need. Moreover, you save all of us money by offering prices lower than those of your competitors.
With PRN's unwavering support and timely interventions, we've been able to provide consistent patient care, even in urgent situations. Their availability and genuine care make all the difference.
PRN strikes the perfect balance with top-notch customer service, competitive prices, and non-intrusive communication. We're extremely satisfied with our partnership.
Latest sourcing and shortage intelligence for licensed healthcare buyers.
August 12, 2026
Updated October 2026. Kenalog's new owner, Piramal, describes supply as tight with no timeframe for its new contract manufacturer, FDA's shortage data shows no Kenalog entry, and most generic lines need confirming at the NDC level.
July 29, 2026
Updated October 2026. FDA's shortage data shows D50 and sodium bicarbonate 8.4% syringes constrained, lidocaine 2% and atropine syringes split by manufacturer, and an FDA warning letter to the IMS plant as a separate watch item.
July 8, 2026
Updated October 2026. Omnipaque (Iohexol) is not on FDA's shortage list, but open recall entries, a GE HealthCare capacity remark, Guerbet's Raleigh batch-release work and Hengrui discontinuations are worth tracking. No public source gives NDC-level availability.
June 24, 2026
Updated October 2026. FDA does not list tocilizumab, but the American College of Rheumatology reports a Tyenne shortage as of July 2026, alongside a Class I recall of one 400 mg lot and shifting payer preferences.
June 10, 2026
Updated October 2026. FDA lists no current shortage for labetalol, amiodarone, nicardipine or diltiazem, but Baxter and Pfizer report 100 mg/20 mL labetalol constraints into 2027 and Baxter reports Nexterone 360 mg/200 mL as limited.
May 13, 2026
Updated October 2026. Marcaine Spinal 0409-1761-10 is listed as unavailable with next delivery in December 2026, Bupivacaine Spinal 0409-3613-01 is listed as available, and extended dating and a separate Huons recall add lot and kit checks for buyers.
April 29, 2026
Updated October 2026. An Injectafer boxed warning, new generic ferric carboxymaltose NDCs, a UnitedHealthcare step change and a Viatris iron sucrose discontinuation are changing IV iron planning. FDA data shows no ferumoxytol shortage record.
April 22, 2026
Updated October 2026. FDA lists Thrombin-JMI as not available and Pfizer shows its lyophilized vials and kits as Depleted into 2027, while Thrombin-JMI Liquid vials are listed as available with different handling and no kit.
April 3, 2026
Updated April 2026. Berry Friendly & Safe vial and cap shortages can affect automation, lead times, substitutions, and dispensing continuity for pharmacy buyers.
April 1, 2026
Updated April 2026. Triamcinolone acetonide injectable suspension remains a mixed-supply category rather than a clean available-or-discontinued story, with meaningful differences by NDC, vial size, and manufacturer.
March 1, 2026
Early-2026 supply risk has narrowed into high-impact categories, with TICE BCG still allocation-managed and manufacturer-specific sterile injectable gaps continuing to affect procurement planning.
Tell us what you need and your timeline. We will follow up quickly with next steps.